Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3117-3122

  De Cremoux, P ^a   Extra, J M ^a   Denis, M G ^b   Pierga, J Y ^a   Bourstyn, E ^a   Nos, C ^a   Clough, K B ^a   Boudou, E ^a   Martin, E C ^a   Muller A ^a   Pouillart, P ^a   Magdelenat H ^a  

^a INSTITUT CURIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; BLOOD; BREAST CARCINOMA; CELL LINE; CELL SEPARATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST DISEASES; BREAST NEOPLASMS; CA-15-3 ANTIGEN; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY;

EID: 0033889333     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fagnou, C., Michon, J., Peter, M., Bernoux, A., Oberlin, O., Zucker, J. M., Magdelénat, H., and Delattre, O. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. J. Clin. Oncol., 16: 1707-1711, 1998.
2. Mensink, E., van de Locht, A., Schattenberg, A., Linders, E., Schaap, N., Geurts van Kessel, A., and De Witte, T. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br. J. Haematol., 102: 768-774, 1998.
3. Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P., and Vogelstein, B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (Washington DC), 256: 102-105, 1992.
4. Hayashi, N., Ito, I., Yanagisawa, A., Kato, Y., Nakamori, S., Imaoka, S., Watanabe, H., Ogawa, M., and Nakamura, Y. Genetic diagnosis of lymph node metastasis in colorectal cancer. Lancet, 345: 1257-1259, 1995.
5. Denis, M. G., Lipart, C., Leborgne, J., LeHur, P. A., Galmiche, J. P., Denis, M., Ruud, E., Truchaud, A., and Lustenberger, P. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int. J. Cancer. 74: 540-544, 1997.
6. Eaton, M. C., Hardingham, J. E., Kotasek, D., and Dobrovic, A. Immunobead RT-PCR. A sensitive method for detection of circulating tumor cells. Biotechniques, 22: 100-105, 1997.
7. Battaglia, M., Pedrazzoli, P., Palermo, B., Lanza, A., Bertolini, F., Gibelli, N., Da Prada, G. A., Zambelli, A., Perotti, C., and Robustelli della Cuna, G. Epithelial tumor cell detection and the unsolved problems of nested RT- PCR: a new sensitive one step method without false positive results. Bone Marrow Transplant., 22: 693-698, 1998.
8. Peat, N., Gendler, S. J., Lalani, N., Duhig, T., and Taylor-Papadimitriou, J. Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res., 52: 1954-1960, 1992.
9. Mommers, E., Leonhart, A., von Mensdorff-Pouilly, S., Schol, D., Hilgers, J., Meuer. C., Baak, J., and van Diest, P. Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma in situ of the breast. Int. J. Cancer, 84: 466-469, 1999.
10. Zaretsky, J., Sarid, R., Aylon, Y., Mittelman, L., Wreschner, D., and Keydar, I. Analysis of the promoter of the MUC1 gene overexpressed in breast cancer. FEBS Lett., 19: 189-195, 1999.
11. Walsh, M., Luckie, S., Cummings, M. C., Antalis, T. M., and McGuckin, M. A. Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro. Breast Cancer Res. Treat., 58: 255-266, 2000.
12. Ho, S. B., Niehans, G. A., Lyftogt, C., Yan, P. S., Cherwitz, D. L., Gum, E. T., Dahiya, R., and Kim, Y. S. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res., 53: 641-651, 1993.
13. Mori, M., Mimori, K., Ueo, H., Tsuji, K., Shiraishi, T., Barnard, G. F., Sugimachi, K., and Akiyoshi, T. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J. Clin. Oncol., 16: 128-132. 1998.
14. Zach, O., Kasparu, H., Krieger, O., Hehenwarter, W., Girschilofsky, M., and Lutz, D. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J. Clin. Oncol., 17: 2015, 1999.
15. Wesseling, J., van der Valk, S. W., Vos, H. L., Sonnenberg, A., and Hilkens, J. Episialin (MUC1) overexpression inhibits integrin mediated cell adhesion to extracellular matrix component. J. Cell Biol., 129: 255-265, 1995.
16. Yamamoto, M., Bharti, A., Li, Y., and Kufe, D. Interaction of the DF3/MUC1 breast carcinoma associated antigen and β catenin in cell adhesion. J. Biol. Chem., 272: 12492-12494, 1997.
17. Brugger, W., Buhring, H. J., Grunebach, F., Vogel, W., Kaul, S., Muller. R., Brummendorf, T. H., Ziegler, B. L., Rappold, I., Brossart, P., Scheding, S., and Kanz, L. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J. Clin. Oncol., 17: 1535-1544, 1999.
18. Mullah, B., Livak, K., Andrus, A., and Kenney, P. Efficient synthesis of double dye-labeled oligodeoxyribonucleotide probes and their application in a real time PCR assay. Nucleic Acids Res., 26: 1026-1031, 1998.
19. Kvalheim, G. Diagnosis of minimal residual disease in bone marrow and blood in cancer patients - methods and clinical implications. Acta Oncol., 37: 455-462, 1998.
20. Zippelius, A., Kufer, P., Honold, G., Kollermann, M. W., Oberneder, R., Schlimok, G., Riethmuller, G., and Pantel, K. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J. Clin. Oncol., 15: 2701-2708, 1997.
21. Smith, M. R., Biggar, S., and Hussain, M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res., 55: 2640-2644, 1995.
22. Henke, W., and Loening, S. A. Detection of illegitimate transcripts of prostate-specific antigen mRNA in blood by reverse transcription-polymerase chain reaction. Int. J. Cancer., 77: 164-165, 1998.
23. Gala, J. L., Heusterspreute, M., Loric, S., Hanon, F., Tombal, B., Van Cangh, P., De Nayer, P., and Philippe, M. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization. Clin. Chem., 44: 472-481, 1998.
24. Negrier, C., Vinciguerra, C., Attali, O., Grenier, C., Larcher, M. E., and Dechavanne, M. Illegitimate transcription: its use for studying genetic abnormalities in lymphoblastoid cells from patients with Glanzmann thrombasthenia. Br. J. Haematol., 100: 33-39, 1998.
25. Dingemans, A. M., Brakenhoff, R. H., Postmus, P. E., and Giaccone, G. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab. Invest., 77: 213-220, 1997.
26. Lopez-Guerrero, J. A., Bolufer-Gilabert, P., Sanz-Alonso, M., Barragan-Gonzalez, E., Palau-Perez, J., De la Rubia-Comos, J., Sempere-Talens, A., and Bonanad-Boix, S. Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR). Clin. Chim. Acta., 263: 105-116, 1997.
27. Bostick, P. J., Chatterjee, S., Chi, D. D., Huynh, K. T., Giuliano, A. E., Cote, R., and Hoon, D. S. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. Clin. Oncol., 16: 2632-2640, 1998.
28. Latza, U., Niedobitek, G., Schwarting, R., Nekarda, H., and Stein, H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J. Clin. Pathol., 43: 213-219, 1990.
29. Hardingham, J. E., Kotasek, D., Farmer, B., Butler, R. N., Mi, J. X., Sage, R. E., and Dobrovic, A. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res., 53: 3455-3458, 1993.
30. Naume, B., Borgen, E., Beiske, K., Herstad, T. K., Ravnas, G., Renolen, A., Trachsel, S., Thrane-Steen, K., Funderud, S., and Kvalheim, G. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J. Hematother., 6: 103-114, 1997.